Literature DB >> 3741717

The effects of diabetes mellitus, exercise, and single doses of biguanides upon lactate metabolism in man.

P Fletcher, M R Hirji, S Kuhn, L Alexander, J C Mucklow.   

Abstract

The polymorphism of phenformin oxidation has been investigated in 103 non-insulin-dependent (Type II) diabetics. The frequency distribution was clearly bimodal and 14 poor metabolisers were identified. The frequency of the recessive allele (0.369) was not significantly different from that found previously in non-diabetics. Six of the extensive metabolisers of phenformin were matched for age, sex and oxidizer phenotype with non-diabetic controls. All subjects underwent a standard 3-min exercise test, using a bicycle ergometer, after which plasma lactate concentration was monitored for 90 min. There was no significant difference between groups in lactate accumulation or elimination. Ten extensive metabolisers, ten poor metabolisers and seven non-diabetics (matched for age, sex and phenotype with seven of the diabetic extensive metabolisers) were challenged with a fasting oral dose of phenformin (50 mg), after which plasma lactate, and blood pyruvate and glucose concentrations were monitored for 4 h. A further ten diabetics (five extensive and five poor metabolisers of phenformin) received a single dose of metformin (1 g) following an identical protocol. No significant changes were observed in any group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741717      PMCID: PMC1400987          DOI: 10.1111/j.1365-2125.1986.tb05235.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  THE INFLUENCE OF PHENFORMIN ON BLOOD LACTIC ACID IN NORMAL AND DIABETIC SUBJECTS DURING EXERCISE.

Authors:  F GUETTLER; F B PETERSEN; K KJELDSEN
Journal:  Diabetes       Date:  1963 Sep-Oct       Impact factor: 9.461

2.  Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes.

Authors:  G Schäfer
Journal:  Biochem Pharmacol       Date:  1976-09-15       Impact factor: 5.858

3.  Interaction of biguanides with mitochondrial and synthetic membranes. The role of phospholipids as natural binding sites.

Authors:  G Schäfer
Journal:  Eur J Biochem       Date:  1974-06-01

4.  The influence of phenformin on lactate metabolism in diabetic patients in relation to hypoxia and exercise.

Authors:  L S Hermann; E Nathan; I Ebbesen
Journal:  Acta Med Scand       Date:  1973 Jul-Aug

5.  The effects of obesity and maturity-onset diabetes mellitus on L(+) lactic acid metabolism.

Authors:  J W Doar; D G Cramp
Journal:  Clin Sci       Date:  1970-08       Impact factor: 6.124

6.  Determination of blood glucose using 4-amino phenazone as oxygen acceptor.

Authors:  P Trinder
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

7.  Biguanides and lactic acidosis.

Authors:  P J Phillips; D W Thomas; P E Harding
Journal:  Br Med J       Date:  1977-01-22

8.  Hyperlactataemia in phenformin-treated diabetics.

Authors:  S K Varma; S J Heaney; W G Whyte; R S Walker
Journal:  Br Med J       Date:  1972-01-22

9.  Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.

Authors:  M Nattrass; P G Todd; L Hinks; B Lloyd; K G Alberti
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

10.  Mechanism of action of phenethylbiguanide (Phenformin) in man IV. Effect of phenethylbiguanide (PBG) on glucose tolerance and lactate dynamics in obese nondiabetic and chemical diabetic subjects.

Authors:  F P Cesar; C E Leme; L Y Ohnuma; C R Palomino; B L Wajchenberg
Journal:  Metabolism       Date:  1980-03       Impact factor: 8.694

View more
  4 in total

Review 1.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 3.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

4.  Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial.

Authors:  Jonas M Kristensen; Christian Lillelund; Rasmus Kjøbsted; Jesper B Birk; Nicoline R Andersen; Lars Nybo; Karin Mellberg; Anudharan Balendran; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  Physiol Rep       Date:  2019-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.